These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 1715501)
1. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501 [TBL] [Abstract][Full Text] [Related]
2. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628 [TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007 [TBL] [Abstract][Full Text] [Related]
4. Body proportions before and during growth hormone therapy in children with chronic renal failure. de Graaff LC; Mulder PG; Hokken-Koelega AC Pediatr Nephrol; 2003 Jul; 18(7):679-84. PubMed ID: 12734746 [TBL] [Abstract][Full Text] [Related]
5. [Growth hormone therapy in prepubertal children with chronic renal insufficiency]. Kost'álová L; Misíková Z; Furková K; Lebl J; Simková E; Krásnicanová H Cas Lek Cesk; 1995 Dec; 134(24):788-90. PubMed ID: 8599822 [TBL] [Abstract][Full Text] [Related]
6. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study. Allen DB J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612 [TBL] [Abstract][Full Text] [Related]
7. [Chronic kidney insufficiency: results of treatment with growth hormone]. Hokken-Koelega AC Tijdschr Kindergeneeskd; 1992 Oct; 60(5):177-82. PubMed ID: 1448808 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate. Tönshoff B; Tönshoff C; Mehls O; Pinkowski J; Blum WF; Heinrich U; Stöver B; Gretz N Eur J Pediatr; 1992 Aug; 151(8):601-7. PubMed ID: 1380459 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency. Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189 [TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone therapy on IGF-I, bone GLA-protein and bone mineral content in short children with and without chronic renal failure. Zadik Z; Vaisman N; Lotan D; Vaisman E; Landau D; Blachar Y; Katz A; Drukker A Horm Res; 1992; 38(3-4):145-9. PubMed ID: 1306846 [TBL] [Abstract][Full Text] [Related]
11. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone. Neyzi O; Yordam N; Ocal G; Bundak R; Darendeliler F; Açikgöz E; Berberoğlu M; Günöz H; Saka N; Calikoğlu AS Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775 [TBL] [Abstract][Full Text] [Related]
13. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. Tönshoff B; Mehis O; Heinrich U; Blum WF; Ranke MB; Schauer A J Pediatr; 1990 Apr; 116(4):561-6. PubMed ID: 2319402 [TBL] [Abstract][Full Text] [Related]
14. Predicting the growth response to growth hormone in patients with intrauterine growth retardation. Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180 [TBL] [Abstract][Full Text] [Related]
15. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352 [TBL] [Abstract][Full Text] [Related]
16. Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases. Hokken-Koelega AC; Saenger P; Cappa M; Greggio N; J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():945-52. PubMed ID: 11529400 [TBL] [Abstract][Full Text] [Related]
17. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864 [TBL] [Abstract][Full Text] [Related]
18. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment in growth retarded children with end stage renal failure: effect on free/dissociable IGF-I levels. Bereket A; Lang CH; Blethen SL; Kaskel FJ; Stewart C; Wilson TA J Pediatr Endocrinol Metab; 1997; 10(2):197-202. PubMed ID: 9364353 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical and laboratory parameters during 2 years of growth hormone treatment in prepubertal children with chronic renal failure. Simon D; Neol M; Brun P; Porquet D; Rocchicioli P; Loirat C; Czernichow P Eur J Pediatr; 1996 Aug; 155(8):688-94. PubMed ID: 8839726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]